Acessibilidade / Reportar erro

Study of hepatocellular function in the murine model following hepatic artery selective clamping

Abstract

PURPOSE: To investigate the impact of selective hepatic artery clamping (SHAC) in hepatocellular function. METHODS: Three groups of Wistar male rats were subjected to SHAC ischemia period of 60min: Group A continuous SHAC were subjected to SHAC ischemia period of 60min, Group B intermittent SHAC of 30min with 5min of reperfusion and Group C intermittent SHAC of 15min with 5min of reperfusion. Animals without SHAC were included-Group D. To evaluate hepatocellular function blood markers and hepatic extraction function (HEF) using 99mTc-mebrofenin were performed before and after surgery. Flow cytometry was used to analyze oxidative stress and cell viability. RESULTS: A mortality rate of 7.6% in Group A was observed. HEF maintained normal values between the groups. Flow cytometry demonstrated no significant differences between the groups in viability, type of cell death as well as in the production of reactive oxygen species. CONCLUSIONS: The selective hepatic artery clamping compared to other clamping techniques results on increased cell viability and decreased hepatocyte death. The SHAC is a potential alternative to decrease per-operative bleeding while maintaining hepatocellular function.

Liver; Hepatic Artery; Constriction; Radionuclide Imaging; Rats


acb

6 - ORIGINAL ARTICLE

MODELS, BIOLOGICAL

Study of hepatocellular function in the murine model following hepatic artery selective clamping1 1 Research performed at Biophysics Unit, Faculty of Medicine, Centre of Investigation on Environment, Genetics and Oncobiology (CIMAGO), Universitary Hospital Centre of Coimbra and Applied Molecular Biology Unit, University of Coimbra, Portugal.

José Guilherme TralhãoI; Ana Margarida AbrantesII; Ana Cristina GonçalvesIII; Emir HotiIV; Mafalda LaranjoV; Ricardo MartinsVI; Bárbara OliveirosVII; Dulce CardosoVIII; Ana Bela Sarmento-RibeiroIX; Maria Filomena BotelhoX; Francisco Castro-SousaX

IAssistant Professor, Faculty of Medicine, University of Coimbra, Surgery A, Surgery Department. CHUC, Centre of Investigation on Environment, Genetics and Oncobiology (CIMAGO), Portugal. Conception and design of the study, acquisition of data; drafting the article, final revision

IIAssistant Professor, Faculty of Medicine, University of Coimbra, CIMAGO, Portugal. Acquisition and interpretation of data

IIIFellow PhD degree, Technician, Faculty of Medicine, University of Coimbra, CIMAGO, Portugal. Acquisition and interpretation of data

IVSurgeon, Liver Transplant Unit, Saint Vincents' University Hospital, Dublin, Ireland. Acquisition of data, final revision

VFellow PhD degree, Faculty of Medicine, University of Coimbra, CIMAGO, Portugal. Acquisition and interpretation of data

VISurgeon, Surgery A, Surgery Department, CHUC, Coimbra, Portugal. Acquisition and interpretation of data

VIIAssistant Professor, Faculty of Medicine, University of Coimbra, Portugal. Statistical analysis

VIIINuclear medicine technologist, Universitary Hospital Centre of Coimbra, Portugal. Acquisition and interpretation of data

IXAssistant Professor, Faculty of Medicine, University of Coimbra, CIMAGO, Portugal. Acquisition and interpretation of data, final revision

XFull Professor, Faculty of Medicine, University of Coimbra, CIMAGO, Portugal. Conception and design of the study, critical revision

Correspondence Correspondence: José Guilherme Tralhão Departamento de Cirurgia, Serviço de Cirurgia A. Centro Hospitalar Universitário de Coimbra Praceta Mota Pinto 3000-075 Coimbra Portugal Tel.: (351)239 400 417 Fax: (351)239 480 258 jglrt@hotmail.com

ABSTRACT

PURPOSE: To investigate the impact of selective hepatic artery clamping (SHAC) in hepatocellular function.

METHODS: Three groups of Wistar male rats were subjected to SHAC ischemia period of 60min: Group A continuous SHAC were subjected to SHAC ischemia period of 60min, Group B intermittent SHAC of 30min with 5min of reperfusion and Group C intermittent SHAC of 15min with 5min of reperfusion. Animals without SHAC were included-Group D. To evaluate hepatocellular function blood markers and hepatic extraction function (HEF) using 99mTc-mebrofenin were performed before and after surgery. Flow cytometry was used to analyze oxidative stress and cell viability.

RESULTS: A mortality rate of 7.6% in Group A was observed. HEF maintained normal values between the groups. Flow cytometry demonstrated no significant differences between the groups in viability, type of cell death as well as in the production of reactive oxygen species.

CONCLUSIONS: The selective hepatic artery clamping compared to other clamping techniques results on increased cell viability and decreased hepatocyte death. The SHAC is a potential alternative to decrease per-operative bleeding while maintaining hepatocellular function.

Key words: Liver. Hepatic Artery. Constriction.Radionuclide Imaging. Rats.

Introduction

Surgical treatment of primary or metastatic liver tumors remains the only therapeutic alternative with curative potential. Several clinical factors have been reported as predictive of survival without disease after curative surgical treatment. Intraoperative blood loss and transfusion are major factors influencing morbidity, mortality and survival following liver resection1. Therefore, all care should be taken to reduce per-operative bleeding and transfusion. Hepatic vascular inflow occlusion, called Pringle maneuver, associated with low central venous pressure are used to prevent bleeding during transection of hepatic parenchyma. However, this maneuver causes ischemia and reperfusion injury2-4. Two protective strategies have been proposed to enable longer duration of ischemia, namely intermittent clamping and ischemia preconditioning. Intermittent Pringle maneuver consists of successive cycles of 15 minutes of inflow occlusion alternated by periods of five minutes of reperfusion.

Very long duration periods of ischemia have been reported using intermittent Pringle maneuver. However, this technique has inherent disadvantages such as back flow bleeding from the hepatic veins, bleeding during reperfusion intervals as well as a time limit usually around 60 minutes4-7.

With the advent of liver resection by laparoscopy and the effects of pneumoperitoneum on the portal vein flow8, the selective hepatic artery clamping (SHAC) has been advocated. In fact, the increased intraperitoneal pressure necessary to perform laparoscopic operations reduces the portal venous flow8,9. The extent of the volume flow reduction is related to the level of intraperitoneal pressure.

The aim of this experimental study was to estimate the impact of different duration of SHAC on the hepatocellular function, viability or death of hepatocytes in an animal model with normal liver.

Methods

All the procedures were performed in accordance with the Coimbra University Institution Animal Care and were approved by the local animal ethics committee.

Two months old male Wistar rats were used in all experiments. The animals were fed a laboratory diet with water and food ad libitum until surgery and were kept under constant environment conditions with 12-hour light-dark cycle.

Four groups of animals were studied. The control group consisted of animals subjected to 60 minutes laparotomy without SHAC - Group D; two experimental groups (C and B) received respectively intermittent SHAC of 15 or 30 minutes followed by five minutes of reperfusion. Finally the experimental Group A was submitted to 60 minutes of continuous SHAC.

Operative procedures

All animals were anesthetized with xylazine (Bayer, Leverkuse, Germany) and ketamine (Rhône Mérieux, Lyon, France). The abdomen was opened through a midline incision and liver was free from its ligaments. The portal triad was dissected and a microvascular clamp (Aesculap, San Francisco, CA) was placed in order to induce SHAC. At the end of SHAC period a hepatic biopsy of the left lobe was performed. Finally, the survival of the animals for 24 hours in each group was monitored.

Serum enzymes analysis

Serum levels of asparate-aminotransferase (AST), alanine-aminotransferase (ALT), alkaline-phosphatase (AP), gamma-glutamyl-transpeptidase (GGT), total-bilirubin (TB), lactic-acid-dehydrigenase (LDH) were used as blood markers of hepatic injury. Blood samples were obtained three days before laparotomy and one hour after surgery. Blood cells were pelleted by immediate centrifugation at 10 000 g for eight minutes at 4ºC. Enzyme levels were measured using a serum multiple biochemical analyzer as described10.

Hepatic extraction fraction (HEF) evaluation by radioisotopic methods

For the HEF calculation, an IDA derivative, 3-bromo-2,4,6-trimethylacetanilidoiminodiacetic acid labelled with technetium-99m (99mTc-mebofrenin) was used. The labeling procedure was performed by adding 99mTc freshly eluted to a mebrofenin kit (Bridatec, GE-Amersham Health, Eindhoven, the Netherlands) constituted by 40.0 mg of mebrofenin as sodium salt associated with 0.3 mg of stannous chloride dehydrate. Quality control performed according to the manufacturer was always carried out before animal administration. The 99mTc-mebrofenin complex formed is stable for at least 6 hours after reconstitution. Related to dosimetry, the target organ which has the highest estimated absorbed dose is the large bowel (9.2 E-02 mGy/MBq) according to Medical Internal Radiation Dose Committee (MIRD) guidelines.

Data acquisition

99mTc-Mebrofenin scintigraphy was performed in all animals after fasting for at least six hours. Data acquisition was performed by a single detector gamma camera (GE Maxicamera 400 AC, Milwaukee, USA) coupled with a low energy high resolution parallel hole collimator, controlled by a GenieAcq computer. Data were dynamically collected after the bolus injection of 185 MBq 99mTc-Mebrofenin into an animal tail vein, for 128*128 matrix, every second during the first minute, followed by 59 frames of 60 seconds each. After dynamic acquisition, static images, anterior, 256*256 were performed with an individual duration of 67 seconds for decay correction. The animals' position was with the upper abdomen and cardiac area included in the gamma camera field of view. Energy discrimination was centered on 140 keV with a 20% energy window. After acquisition the data were transferred to a work station Xeleris for processing.

Data processing

On the dynamic sequence of images, regions of interest (ROIs) were flagged over the cardiac region and right hepatic lobe, avoiding the gall-bladder and main intrahepatic biliary ducts. With the total counts, time-activity curves were generated from the ROIs. The HEF was calculated through deconvolution analysis of the first pass curve. Additionally, the time of maximum liver activity (Tmax) and half time of the normalized liver curve (T1/2) were calculated. Values of 98.5±2.7% for HEF, 18±4.6 min for Tmax and 20.9±14.6 min for T1/2 were considered normal11.

Liver cell isolation

Liver cells were isolated from liver biopsy obtained at the end of surgery by using collagenase (Collagenase Hepatocyte Qualified - Gibco / BRL) as described12.

Flow cytometry assays

After liver cell isolation, viability and death, oxidative stress and mitochondrial membrane potential were investigated by flow cytometry. Flow cytometry analysis was performed using a six-parameter, four-color FACSCaliburTM flow cytometer (Becton Dickinson, San Jose, CA) equipped with a 15 nW argon laser. For each assay 106 cells were used and at least 10 000 events were collected by acquisition using CellQuest software (Becton Dickinson) and analyzed using Paint-a-gate software (Becton Dickinson).

Cell death and viability analysis

Hepatocytes isolated from hepatectomy specimens and were stained simultaneously with Annexin-V, labelled with the fluorescent probe, fluorescein isothyocianate (FITC), and propidium iodide, according to manufacturer's recommended protocol (Immunotech Kit). This assay discriminates among intact cells (AV-/PI-), early apoptotic cells (AV+/PI-) and late apoptotic or necrotic cells (AV+/PI+)13,14. Briefly, cells were washed with ice-cold phosphate buffer solution (PBS) by centrifugation at 500g for five min, resuspended in 100µL of binding buffer and incubated with 1µL of AV-FITC and 5 µL of PI solutions for 10 min on ice in the dark. After incubation time, cells were diluted in 400 µL of ice-cold binding buffer, and analyzed by flow cytometry.

Evaluation of apoptotic proteins expression by flow cytometry

To evaluate the levels of apoptotic proteins modulators we analyze by flow cytometry the expression of the proapoptotic protein BAX, the antiapoptotic BCL-2 and the ligand of Tumor Necrosis Factor (TNF) family, TRAIL. The levels of cellular fluorescence are proportional to the concentration of apoptotic proteins in each cell. After surgery, 106 of liver cells were centrifuged and incubated with monoclonal antibodies anti-BAX, BCL-2 and TRAIL ligand, according with manufactured protocols. The results are presented as Mean Fluorescence Intensity (MFI) arbitrary units. This value represents the medium of fluorescence intensity detected in the cells, which is proportional to the number of molecules labeled by the antibody.

Reactive oxygen species production

The accumulation of reactive oxygen species (ROS) in hepatocytes, namely peroxides, was determined using 2',7'-dichlorodihydrofluorescein diacetate (DCFH2-DA) (Invitrogen), a stable nonfluorescent lipid permeable compound that is converted to DCFH2 by intracellular esterases. Then, DCFH2 is oxidized by intracellular ROS to form the impermeable fluorescent compound DCF that emits green fluorescence, upon excitation at 488 nm, proportionally to intracellular ROS levels15.

Hepatocytes were treated with 5 µM DCFH2-DA for 30 minutes, at 37ºC in the dark. Cells were then washed twice with PBS, resuspended in PBS, and DCF was detected by flow cytometry. Results are presented as Mean Fluorescence Intensity (MFI) values16.

Mitochondrial membrane potential measurement

The integrity of the inner mitochondrial membrane can be measured by the gradient potential across this membrane, the mitochondrial membrane potential, using the dye 5,5',6,6'-tethrachloro-1,1'3,3'-tethraethylbenzimidazolcarbocyanine iodide (JC-1). This lipophilic cationic probe exists in a monomeric form emitting at 527 nm (green fluorescence) and is able to reverse form aggregates, which are associated with a large shift in the emission (590 nm, greenish-orange fluorescence) as the mitochondrial membrane becomes more polarized.

Mitochondrial membrane potential

in hepatocytes was measured using JC1 (Molecular Probes), as described by others (16). Briefly, cells were washed with PBS throughcentrifugation at 300g during five min and incubated with JC-1 at final concentration of 5 µg/mL for 15 min at 37ºC, in the dark. At the end of the incubation period, the cells were washed twice in PBS, resuspended in a total volume of 500 µL and analyzed by flow cytometry. The results are presented as monomer/aggregate ratio.

Statistical analysis

Statistical analysis was performed using Kruskal-Wallis test and Mann-Whitney U test for multiple comparisons with Bonferroni correction whenever statistical significance was obtained in Kruskall-Wallis test. Analysis was carried out in SPSS, version 17.0, and evaluated at 5% significant level.

Results

There was no operative mortality. However, the postoperative mortality was 7.6% in animals that were subjected to 60 min of continuous SHAC (Group A) and 0% in other groups. Therefore, we demonstrated an increased mortality in Group A, however, this did not reach a statistical significance (ns).

There was an overall increase of postoperative values of AST, ALT, GGT, AP, total bilirubin and LDH as compared to the preoperative values. However, no differences between Groups A, B, C and D were observed.

The study of hepatocellular function through the evaluation of hepatocyte extraction fraction using 99mTc-mebrofenin remained normal without differences between the four groups.

To evaluate the impact of different types of SHAC in hepatocytes viability, cells were stained with annexin V and propidium iodide and analysed by flow cytometry as described above (Figure 1). As we can observe rat hepatocytes submitted to 15 minutes intermittent SHAC (Group C) show higher cell viability than other groups. On the other hand, the hepatocytes of rats submitted to 60 minutes of continuous SHAC (Group A) and to intermittent SHAC of 30 minutes followed by five minutes of reperfusion (Group B), show a decrease in cell viability and an increase in cell death, in particular by late apoptosis and necrosis (Figure 1A) but without statistical differences between groups.


In Figure 2A we can observe the effect of different types of SHAC in hepatocytes peroxides levels. As we can see hepatic cells submitted to 60 minutes of continuous SHAC (Group A) present a decreased in ROS production when compared to control group (Group D). On the other hand, the hepatocytes isolated from rats submitted to intermittent SHAC of 30 minutes followed by five minutes of reperfusion (Group B) and to intermitted SHAC of 15 minutes followed by five minutes of reperfusion (Group C) showed higher ROS levels. However, no statistical differences were found between rats submitted or not to SHAC.



We also evaluated the repercussion of SHAC in mitochondria function by determining the mitochondrial membrane potential through the JC1 monomers/aggregates (M/A) ratio (Figure 2B). Besides the variations observed in JC1 M/A ratio in the different rat groups no statistical differences were found between rats who had and had not SHAC.

Finally, we analyzed the expression of the apoptotic protein modulators, BAX, BCL-2 and TRAIL ligand (Figure 3). We observed a decreased expression of these proteins in all groups, when compared to control group (Group D), but the results were not statistically significant. However, hepatocytes obtained from rats submitted to 60 minutes of continuous SHAC (Group A) and to intermittent SHAC of 30 minutes followed by five minutes of reperfusion (Group B) present an increase in BAX/BCL2 ratio compared to control group (Group D). These observations may result from a higher percentage of cell death observed in the groups, and might implicate the mitochondria in cell death induced by SHAC.


Discussion

Blood loss and per-operative blood transfusions cause morbidity and mortality after hepatectomy. Different methods of vascular control such as the Pringle maneuver, selective clamping of left or right hepatic arteries or portal vein branches, the supra-selective intrahepatic vascular occlusion or total vascular exclusion are used to reduce bleeding during liver resection. However, all these techniques can lead to ischemia or reperfusion injury.

In addition, activation of Kupffer cells may take place, leading in turn to production of reactive oxygen species or cytokines such as tumor necrosis factor or interleukin 8 and consequent injury of endothelial cells of liver parenchyma. To date, studies have suggested that ischemia induced liver injury or reperfusion after clamping of the portal triad can promote metastases and consequently lower patients' survival10. Animal experimental studies submitted to 20 or 30 min of selective lobe ischemia, showed that tumor progression was higher in the lobe selectively clamped8. In fact, microvascular ischemia is associated with changes in endothelial cells that increase the adhesion ability of tumor cells to the endothelium, promoting the progression of liver metastases. Another possible mechanism to explain the idea that occlusion of the portal triad stimulates the progression of liver metastases was proposed in an experimental study in a rat model subjected to 45 min of clamping showed that there was a profound change of liver microcirculation leading to cell necrosis due to hypoxia17. Prolonged hypoxia induces in turn the activation of factor 1α which in turn promotes activation of several genes and subsequent synthesis of proangiogenic growth factors, proliferation and differentiation, an emerging ideal microenvironment for tumorigenesis17. However, this correlation between clamping of the hepatic pedicle and the acceleration of tumor growth is observed only after continuous clamping. In fact, same authors verified that intermittent clamping seemed to have a protective effect against metastatic growth because it is associated with absent or less necrosis of the liver parenchyma and hepatocellular function18,19. These results are consistent with experimental and clinical studies conducted by us and others showing that the liver parenchyma tolerates better intermittent hepatic pedicle clamping18,19.

Although the intermittent clamping of the hepatic pedicle for 15 min in patients with a normal liver can be applied for more than 60 min, the purpose of this study was to evaluate long continuous selective hepatic artery clamping, results on the same level of protection of liver parenchyma and hepatocellular function. Eventually, this surgical strategy might allow a reduction of intraoperative bleeding during hepatectomy maintaining the portal blood supply, and so reducing the risk of hypoxia of the parenchyma.

A clinical study showed that the Pringle maneuver with clamping duration lasting 15 minutes, followed by five minutes of reperfusion in patients undergoing liver resection, increases the tolerance of the liver parenchyma compared to continuous clamping particularly in patients with chronic liver diseases19.

In our study, we found that the SHAC was not associated with a statistically significant increase in mortality compared to animals that were continuously clamped for 15 minutes or not clamped. Our study suggests that this strategy has a relative advantage over the Pringle maneuver as far as the postoperative mortality is concerned.

The study of hepatocyte function has been evaluated by multiple methods. We opted for biochemical evaluation by studying preoperative and postoperative blood parameters (normally used in biological assessment of liver function) and the study of hepatocyte extraction fraction using 99mTc-mebrofenin. The HEF by the radioisotope methods evaluate the capacity of hepatocytes to uptake the radiopharmaceutical, carry it in the cytoplasm and excrete it into the bile ducts. So, we can take during this study various aspects of the dynamic function of hepatocytes and more accurately assess their function. In our study we observed an overall increase of the postoperative values (compared to preoperative values) of ALT, AST, GGT, AP, total bilirubin and LDH in all animals subjected to different protocols of SHAC but no differences among the four groups. Second, the dynamic evaluation of hepatocellular function through the study of HEF by radioisotope methods showed maintenance of normal levels of HEF and no statistically significant differences between different groups.

In this study we found that different duration periods of SHAC (60 and 30 min) induce significant changes in the viability of hepatocytes isolated from the liver of the rats. The methodology revealed that the percentage of viable hepatocyte cells (not stained with annexin V and propidium iodide) and cells in late apoptosis/necrosis (labelled simultaneously with annexin V and propidium iodide) was not statistically significant between the groups submitted to different SHAC types versus the control group (no clamping done).

To evaluate the mechanisms involved in the viability and death of hepatocytes we analyzed peroxide levels, the expression of apoptotic protein modulators and the role of mitochondria through the change of mitochondrial membrane potential.

We have not found statistically differences in peroxide levels between the animals who were and were not submitted to SHAC. However, in hepatic cells obtained from rat livers submitted to intermitted SHAC of 30 minutes followed by five minutes of reperfusion we observed a decrease in M/A ratio, in agreement with the higher cell viability found in this rat group. Usually, a decrease in monomer/aggregated JC1 ratio indicates an increase in the mitochondrial membrane potential that is related with proliferative capacity.

On the other hand an increase in monomer/aggregated JC1 ratio (M/A ratio) indicates a decrease in the mitochondrial membrane potential, implicating the mitochondria in the cell death20. The decrease in cell viability observed in rats submitted to 60 minutes of continuous SHAC and to intermittent SHAC of 30 minutes followed by five minutes of reperfusion produces a higher susceptibility of the hepatocytes to death that may be related to the observed increase in the ratio between the pro-apoptotic and anti-apoptotic proteins (BAX/BCL2 ratio). This increase is in agreement with the higher percentage of cell death observed in these groups and might implicate the mitochondria in cell death induced by SHAC.

Conclusions

Selective hepatic artery clamping is associated with an increase in cell viability and a decrease in the cell death compared to Pringle maneuver. This clamping technique may be an alternative to the Pringle maneuver, taking into account the changes of portal blood flow caused by pneumoperitoneum.

Received: May 20, 2013

Review: July 19, 2013

Accepted: Aug 21, 2013

Conflict of interest: none

Financial source: CIMAGO

  • 1- Nagorney DM, van Heerden JA, Ilstrup DM, Adson MA.Primary hepatic malignancy: surgical management and determinants of survival. Surgery. 1989;106:740-8.
  • 2- Horiuchi T, Muraoka R, Tabo T, Uchinami M, Kimura N, Tanigawa N. Optimal cycles of hepatic ischemia and reperfusion for intermittent pedicle clamping during liver surgery. Arch Surg. 1995;130:754-8.
  • 3- Isozaki H, Adam R, Gigou M Szekely AM, Shen M, Bismuth H. Experimental study of the protective effect of intermittent hepatic pedicle clamping in the rat. Br J Surg. 1992;79:310-3.
  • 4- Belghiti J, Noun R, Malafosse R Jagot P, Sauvanet A, Pierangeli F, Marty J, Farges O. Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann Surg. 1999;229:369-75.
  • 5- Teoh N, Leclercq I, Pena AD, Farrell G. Low-dose TNF-alpha protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning. Hepatology. 2003;37:118-28.
  • 6- Clavien PA, Yadav S, Sindram D, Bentley R. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg. 2000;232:155-62.
  • 7- Rudiger HA, Kang KJ, Sindram D, Riehle H, Clavien P. Comparison of ischemic preconditioning and intermittent and continuous inflow occlusion in the murine liver. Ann Surg. 2002;235:400-7.
  • 8- Takagi S. Hepatic and portal vein blood flow during carbon dioxide pneumoperitoneum for laparoscopic hepatectomy. Surg Endosc. 1998;12(5):427-31.
  • 9- Jakimowicz J, Stultiëns G, Smulders F. Laparoscopic insufflation of the abdomen reduces portal venous flow. Surg Endosc. 1998;12(2):129-32.
  • 10- van der Bilt JD, Kranenburg O, Nijkamp MW, Smakman N, Veenendaal LM, Te Velde EA, Voest EE, van Diest PJ, Borel Rinkes IH. Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model. Hepatology. 2005;42:165-75.
  • 11- Lima JMP, Lima JJP, Isidoro J, Lapa P. A new method for quantification of hepatobiliary scintigraphy using Tc-99m mebrofenin. A comparative study. Rev Esp Med Nucl. 2003;22(4):44-9.
  • 12- Tralhao JG, Roudier J, Morosan S, Giannini C, Tu H, Goulenok C, Carnot F, Zavala F, Joulin V, Kremsdorf D, Bréchot C. Paracrine in vivo inhibitory effects of hepatitis B virus X protein (HBx) on liver cell proliferation: an alternative mechanism of HBx-related pathogenesis. Proc Natl Acad Sci U S A. 2002;99:6991-6.
  • 13- Aubry JP, Blaecke A, Lecoanet-Henchoz S, Jeannin P, Herbault N, Caron G, Moine V, Bonnefoy JY. Annexin-V used for measuring apoptosis in the early events of cellular cytotoxicity. Cytometry. 1999;37:197-204.
  • 14- Dourado M, Sarmento AB, Pereira SV, Alves V, Silva T, Pinto AM, Rosa MS. CD26/DPPIV expression and 8-azaguanine response in T-acute lymphoblastic leukemia cell lines in culture. Pathophysiology. 2007;14:3-10.
  • 15- Halliwell B, Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol. 2004;142:231-55.
  • 16- Almeida S, Sarmento-Ribeiro AB, Januário C, Almeida S, Sarmento-Ribeiro AB, Januário C, Rego AC, Oliveira CR. Evidence of apoptosis and mitochondrial abnormalities in peripheral blood cells of Huntington's disease patients. Biochem Biophys Res Commun. 2008;374:599-603.
  • 17- Brahimi-Horn C, Pouysséqur J. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion. Bull Cancer. 2006;93(8):E73-80.
  • 18- Man K, Fan ST, Ng IO, Lo CM, Liu CL, Yu WC, Wong J. Tolerance of the liver to intermittent pringle maneuver in hepatectomy for liver tumors. Arch Surg. 1999;134:533-9.
  • 19- Ishizaki Y, Yoshimoto J, Miwa K, Sugo H, Kawasaki S. Safety of prolonged intermittent pringle maneuver during hepatic resection. Arch Surg. 2006;141:649-53.
  • 20- Martinou JC, Youle RJ. Mitochondria in apoptosis: bcl-2 family members and mitochondrial dynamics. Dev Cell. 2011;21(1):92-101.
  • Correspondence:
    José Guilherme Tralhão
    Departamento de Cirurgia, Serviço de Cirurgia A. Centro Hospitalar Universitário de Coimbra Praceta Mota Pinto
    3000-075 Coimbra Portugal
    Tel.: (351)239 400 417
    Fax: (351)239 480 258
  • 1
    Research performed at Biophysics Unit, Faculty of Medicine, Centre of Investigation on Environment, Genetics and Oncobiology (CIMAGO), Universitary Hospital Centre of Coimbra and Applied Molecular Biology Unit, University of Coimbra, Portugal.
  • Publication Dates

    • Publication in this collection
      29 Aug 2013
    • Date of issue
      Sept 2013

    History

    • Received
      20 May 2013
    • Accepted
      21 Aug 2013
    • Reviewed
      19 July 2013
    Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia https://actacirbras.com.br/ - São Paulo - SP - Brazil
    E-mail: actacirbras@gmail.com